CUSIP G6333L101StockQ4 2025
24 filings · latest Jan 3, 2022
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Captrust Financial Advisors | 138.6K | $46.4K |
| 2 | Gen-Wealth Partners Inc | 84.6K | $28.4K |
| 3 | Blue Bell Private Wealth Management, LLC | 66 | $22 |
| 4 | Cypress Capital Management LLC (Wy) | 66 | $22 |
| 4 | Feb 11, 2021 | Ra Capital Management, L.P. | 13G/A | — | — | SEC |
| 5 | Feb 10, 2021 | Sabby Management, LLC | 13G | 5.3% | 7.75M | SEC |
| 6 | Feb 10, 2021 | Advent Life Sciences LLP | 13D/A | 3.4% | 2.86M | SEC |
| 7 | Feb 9, 2021 | Pivotal Bioventure Partners Fund I, L.P. | 13G/A | 1.2% | 945.1K | SEC |
| 8 | Feb 8, 2021 | Ra Capital Management, L.P. | 13G/A | 10.6% | 13.73M | SEC |
| 9 | Feb 3, 2021 | Canaan X L.P. | 13G/A | 4.0% | 1.73M | SEC |
| 10 | Jan 29, 2021 | Intracoastal Capital, LLC | 13G/A | 5.0% | 2.58M | SEC |
See the full Schedule 13D/13G history for Iterum Therapeutics PLC Shs New.
Unlock full history